Paul LaViolette
Paul joined SV Health Advisers in 2009 and is focused on medical devices investments and brings over 35 years of global medical technology management experience.
Paul was most recently Chief Operating Officer at Boston Scientific Corporation (BSC), an $8 billion medical device leader. During his 15 years at BSC, he served as Chief Operating Officer, Group President Cardiovascular, President, Cardiology, Group President, Endosurgery and President, International as the company grew revenues over 20 times. Paul integrated two dozen acquisitions and led extensive product development, operations and worldwide commercial organizations. He previously held marketing and general management positions at CR Bard, and various marketing roles at Kendall (Covidien).
Paul serves as Vice Chairman of the Innovation Advisory Board for the Partners Health System and is Chairman for the Medical Device Manufacturers Association.
Paul received his BA in Psychology from Fairfield University and his MBA from Boston College.
Current Board Seats
Bardy Diagnostics
CardioFocus *
CardioKinetix
Cibiem
CSA Medical
Direct Flow Medical *
Endotronix *
Soffio
TransEnterix *
ValenTX *
Ximedica *
External Board Seats
Axon Therapies
Corvia Medical *
*Chairman